Recordati

Recordati is a global pharmaceutical company based in Milan, Italy, with a history dating back to 1926. It operates in approximately 150 countries and employs around 4,580 people. The company focuses on developing, manufacturing, and commercializing medicines for both common diseases and rare conditions, emphasizing social and environmental responsibility. With fully integrated operations, Recordati covers research and development, manufacturing, and commercialization. It operates seven industrial plants and two chemical plants, supporting a diverse portfolio that includes prescription drugs for various medical conditions, over-the-counter pharmaceuticals, cosmetics, dietary supplements, and active pharmaceutical ingredients. Recordati markets over 190 drugs worldwide, including proprietary products like Zanidip®. The company serves a wide range of customers, including healthcare professionals, hospitals, and pharmacies. Recordati has expanded through acquisitions and licensing agreements, enhancing its presence in the rare diseases sector and strengthening its product offerings. Overall, Recordati is committed to innovation and improving health outcomes globally.